(Q43748463)

26 November 2017

Cerivastatin and gemfibrozil-associated rhabdomyolysis (English)

1 reference

26 November 2017

0 references

J Bruno-Joyce

1

1 reference

26 November 2017

J M Dugas

series ordinal

2

1 reference

26 November 2017

O E MacCausland

series ordinal

3

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Annals of Pharmacotherapy

26 November 2017

1 reference

26 November 2017

35

1 reference

26 November 2017

1016-1019

1 reference

26 November 2017

9

1 reference

Cerivastatin: a review of its pharmacological properties and therapeutic efficacy in the management of hypercholesterolaemia

26 November 2017

1 reference

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

21 January 2018

1 reference

Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy

21 January 2018

1 reference

21 January 2018

1 reference

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A116

1 reference

26 November 2017

1 reference